Dr. Omar Ishrak joined Intel Corporation’s board of directors in March 2017 and was named chair of the board in January 2020. Ishrak stepped down as chair in January 2023 and remains on the board as an independent director.
Ishrak was executive chairman of the board of Medtronic PLC, a global medical technology company, until his retirement in December 2020. Ishrak served as chairman and CEO of Medtronic from June 2011 to April 2020. Prior to joining Medtronic, Ishrak spent 16 years in various roles with General Electric Co., most recently as president and chief executive officer of GE Healthcare Systems, a division of GE Healthcare.
Ishrak is a member of the board of directors of Amgen Inc., a biopharmaceutical company, and Allurion Technologies Inc., a healthcare company. He also is a member of the board of trustees of the Asia Society, which promotes mutual understanding and strengthening partnerships among peoples, leaders, and institutions of Asia and the United States in a global context. He is also a member of the Minnesota Public Radio board of trustees. Ishrak has served on the board of directors of Compute Health Acquisition Corp., a SPAC prior to its Allurion Technologies acquisition.
Ishrak earned a Bachelor of Science and a Doctor of Philosophy in electrical engineering from the University of London, King’s College.